United Therapeutics Corp. (UTHR)
473.12
-12.24
(-2.52%)
USD |
NASDAQ |
Feb 09, 16:00
473.50
+0.38
(+0.08%)
Pre-Market: 20:00
United Therapeutics Market Cap : 20.37B for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 4.345B |
| Gilead Sciences, Inc. | 188.19B |
| Johnson & Johnson | 574.95B |
| Catalyst Pharmaceuticals, Inc. | 3.005B |
| MannKind Corp. | 1.815B |
Market Cap Related Metrics
| PE Ratio | 17.93 |
| PS Ratio | 7.293 |
| PEG Ratio | 1.129 |
| Price to Book Value | 3.091 |
| Price to Free Cash Flow | 20.44 |
| Price | 473.12 |
| Earnings Yield | 5.58% |
| PEGY Ratio | 1.129 |
| Operating PE Ratio | 15.05 |
| Normalized PE Ratio | 17.73 |